Constant Humidity & Temperature Chamber THC-450

Features

• Large external water tank supports extended uninterrupted operation for prolonged testing.
• Industrial-grade stainless steel chamber and shelves resist corrosion and chemical exposure.
• Double-door thermal barrier design with toughened glass maintains stable internal conditions.
• Advanced compressor system features intelligent cycling control for consistent low-temperature performance.
• 3D heating technolog ensures all shelf positions maintain identical temperature profiles.
• Smart humidity management with auto-refill and backup reservoir prevents system dry-out.
• Dynamic control algorithm enables complex temperature-humidity cycling protocols.
• Programmable for 99-hour sequences with configurable alarm thresholds for all critical parameters.
• Environmentally responsible R134a refrigerant combined with energy-efficient operation.
• Optional UV disinfection system provides automated decontamination between sample batches

Specifications

Introduction about incubator

Vaccine development and production are critically dependent on incubators at multiple stages. In the research and discovery phase, incubators are used to culture the target pathogen (virus or bacterium) under biosafe conditions for study and attenuation. They also maintain the cell lines (e.g., Vero, MDCK, HEK-293) used to propagate viruses for vaccine candidates.

During process development, shaking incubators optimize growth conditions for bacterial vaccines (e.g., pertussis) or for yeast/bacterial systems producing recombinant vaccine antigens. In manufacturing, while large-scale bioreactors are used for bulk production, CO2 incubators are indispensable in upstream areas for maintaining master and working cell banks, and for expanding seed cultures that will be inoculated into bioreactors.

They are also vital in the quality control (QC) lab. QC tests for sterility, potency, and adventitious agents all require incubation steps. For example, sterility testing of final vaccine lots involves incubating samples in fluid thioglycollate medium and soybean-casein digest medium at specified temperatures to detect any bacterial or fungal contamination. The incubator’s consistent performance ensures that every vial of vaccine is not only effective but also safe, underpinning global immunization programs.